Prevalence
Clinical
features
Differential
diagnosis
Investigations
Therapy
Prevention
Prognosis
|  |  | | Clinical
features |
Ask about features that might affect your management:
-
recurrent venous thromboembolism
a
-
a known clotting disorder
b
-
a history of clotting disorders in first-degree relatives
c
Why?
-
Thrombophilia is quite common, especially in patients who develop a DVT aged less than 25.
c
-
Factor VLeiden is the commonest disorder.
b
A family history and early or recurrent venous thromboembolism makes thrombophilia more likely
| Patient |
Target Disorder and Reference Standard |
Diagnostic Test |
LR+
(95% CI)
|
Post-test Probability |
LR-
(95% CI)
|
Post-test Probability |
suspected thrombophilia
c

(pre-test probability: 8%)
|
thrombophilia
(thrombophilia blood tests)
|
family history (first degree relative)
|
2.2
(1.3 to
3.5)
|
16% |
0.67
(0.45 to
1.0)
|
6% |
|
|
|
family history and first episode aged < 41
|
3.2
(1.4 to
7.0)
|
22% |
0.81
(0.63 to
1.0)
|
7% |
|
|
|
family history, first episode aged < 41 and previous PE, DVT
|
4.7
(1.3 to
17)
|
30% |
0.89
(0.76 to
1.1)
|
7% |
Factor V Leiden is the commonest thrombophilia
|
Thrombophilia
|
%
(95% CI)
|
factor V Leiden
b
c
|
21%
(17% to 26%)
|
|
factor V Leiden aged < 45 |
23%
|
|
factor V Leiden aged < 25 |
42%
|
|
protein C deficiency |
3%
(1% to 5%)
|
|
protein S deficiency |
2%
(0% to 4%)
|
|
plasminogen deficiency |
1%
(0% to 2%)
|
|
antithrombin III deficiency |
1%
(0% to 2%)
|
Thrombophilia increases the risk of venous thromboembolism
| Outcome |
Risk Factor |
PEER |
OR (95% CI) |
NNH
(95% CI) |
venous thromboembolism b
|
factor V Leiden
independent
|
0.021% |
9.3 (3.6 to
24.1) |
570
(200 to
1800)
|
venous thromboembolism b
|
homocystinaemia
not independent
|
0.021% |
2.95 (2.08 to
4.17) |
2400
(1500 to
4400)
|
|